» Articles » PMID: 29392225

Effect of the Spider Toxin Tx3-3 on Spinal Processing of Sensory Information in Naive and Neuropathic Rats: an in Vivo Electrophysiological Study

Overview
Journal Pain Rep
Publisher Wolters Kluwer
Date 2018 Feb 3
PMID 29392225
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Drugs that counteract nociceptive transmission in the spinal dorsal horn preferentially after nerve injury are being pursued as possible neuropathic pain treatments. In a previous behavioural study, the peptide toxin Tx3-3, which blocks P/Q- and R-type voltage-gated calcium channels, was effective in neuropathic pain models.

Objectives: In the present study, we aimed to investigate the effect of Tx3-3 on dorsal horn neuronal responses in rats under physiological conditions and neuropathic pain condition induced by spinal nerve ligation (SNL).

Methods: In vivo electrophysiological recordings of dorsal horn neuronal response to electrical and natural (mechanical and thermal) stimuli were made in rats under normal physiological state (naive rats) or after the SNL model of neuropathic pain.

Results: Tx3-3 (0.3-100 pmol/site) exhibited greater inhibitory effect on electrical-evoked neuronal response of SNL rats than naive rats, inhibiting nociceptive C-fibre and Aδ-fibre responses only in SNL rats. The wind-up of neurones, a measurement of spinal cord hyperexcitability, was also more susceptible to a dose-related inhibition by Tx3-3 after nerve injury. Moreover, Tx3-3 exhibited higher potency to inhibit mechanical- and thermal-evoked neuronal response in conditions of neuropathy.

Conclusion: Tx3-3 mediated differential inhibitory effect under physiological and neuropathic conditions, exhibiting greater potency in conditions of neuropathic pain.

Citing Articles

Role of Cav2.3 (R-type) Calcium Channel in Pain and Analgesia: A Scoping Review.

de Amorim Ferreira M, Ferreira J Curr Neuropharmacol. 2023; 22(11):1909-1922.

PMID: 37581322 PMC: 11284728. DOI: 10.2174/1570159X21666230811102700.


Current Drug Development Overview: Targeting Voltage-Gated Calcium Channels for the Treatment of Pain.

Antunes F, Campos M, Carvalho V, da Silva Junior C, Magno L, de Souza A Int J Mol Sci. 2023; 24(11).

PMID: 37298174 PMC: 10252546. DOI: 10.3390/ijms24119223.


Critical Pronociceptive Role of Family 2 Voltage-Gated Calcium Channels in a Novel Mouse Model of HIV-Associated Sensory Neuropathy.

Luckemeyer D, Prudente A, de Amorim Ferreira M, da Silva A, Tonello R, Macedo Junior S Mol Neurobiol. 2023; 60(5):2954-2968.

PMID: 36754911 DOI: 10.1007/s12035-023-03244-8.


Pain-related toxins in scorpion and spider venoms: a face to face with ion channels.

Diochot S J Venom Anim Toxins Incl Trop Dis. 2021; 27:e20210026.

PMID: 34925480 PMC: 8667759. DOI: 10.1590/1678-9199-JVATITD-2021-0026.


Anti-inflammatory activities of arthropod peptides: a systematic review.

Santos A, Cruz G, Baptista G J Venom Anim Toxins Incl Trop Dis. 2021; 27:e20200152.

PMID: 34795699 PMC: 8564866. DOI: 10.1590/1678-9199-JVATITD-2020-0152.


References
1.
Ertel E, Campbell K, Harpold M, Hofmann F, Mori Y, Perez-Reyes E . Nomenclature of voltage-gated calcium channels. Neuron. 2000; 25(3):533-5. DOI: 10.1016/s0896-6273(00)81057-0. View

2.
Li C, Song Y, Higuera E, Luo Z . Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci. 2004; 24(39):8494-9. PMC: 1635787. DOI: 10.1523/JNEUROSCI.2982-04.2004. View

3.
Catterall W, Leal K, Nanou E . Calcium channels and short-term synaptic plasticity. J Biol Chem. 2013; 288(15):10742-9. PMC: 3624454. DOI: 10.1074/jbc.R112.411645. View

4.
Luvisetto S, Marinelli S, Panasiti M, DAmato F, Fletcher C, Pavone F . Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels. Neuroscience. 2006; 142(3):823-32. DOI: 10.1016/j.neuroscience.2006.06.049. View

5.
Li C, Zhang X, Matthews E, Li K, Kurwa A, Boroujerdi A . Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain. 2006; 125(1-2):20-34. PMC: 1635965. DOI: 10.1016/j.pain.2006.04.022. View